Lehr Martin A.

Chief Executive Officer

1 company

Good

Trades Analyzed

12M Win Rate

70.0%

Avg 3M Return

-25.9%

Avg 12M Return

+7.4%

Lehr Martin A. is a Chief Executive Officer at Context Therapeutics Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.

Estimated insider holdings value: $2.2M based on current market prices.

Holdings by Company

CNTXJun 9, 2025

Current Shares920.2K

Value$2.19M

Net Activity+193.1K

Bought: 193.1KSold: 0

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 9, 2025	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	100,000	$0.70	$70,080.00	+12.2%	+16.9%	-
Feb 21, 2023	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	5,823	$0.84	$4,900.05	+3.8%	-19.7%	+49.4%
Feb 13, 2023	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	5,606	$0.87	$4,900.77	+3.8%	-41.3%	+38.0%
Feb 6, 2023	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	5,040	$0.97	$4,900.39	+3.5%	-37.0%	+6.2%
Jan 30, 2023	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	7,027	$0.70	$4,900.63	+5.2%	-16.5%	+55.2%
Jan 23, 2023	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	6,839	$0.72	$4,900.83	+5.3%	-17.4%	+44.3%
Jan 17, 2023	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	6,783	$0.74	$4,995.00	+5.5%	-8.2%	+51.8%
Dec 16, 2022	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	20,000	$0.74	$14,796.00	+19.5%	-8.3%	+32.5%
Aug 19, 2022	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	13,000	$1.85	$24,064.30	+14.5%	-36.4%	-41.5%
Dec 16, 2021	CNTX Context Therapeutics Inc.	Chief Executive Officer	Buy	13,000	$3.22	$41,849.60	+1.6%	-44.8%	-77.2%